HIV/AIDS News and Research

RSS

Acquired immune deficiency syndrome or acquired immunodeficiency syndrome (AIDS) is a disease of the human immune system caused by the human immunodeficiency virus (HIV).

Clearer picture of host responses to HIV virus

The first genome-wide association study of an infectious disease, conducted by an international group of researchers through the Center for HIV/AIDS Vaccine Immunology (CHAVI), has yielded a new understanding of why some people can suppress virus levels following HIV infection.

20 Jul 2007

Protecting HIV patients from Hep B

Since the transmission of HIV and Hepatitis B virus (HBV) are so similar, individuals infected with one of these viruses are at a significantly increased risk for contracting the other.

19 Jul 2007

Tibotec Pharmaceuticals submits NDA for investigational HIV treatment

Tibotec Pharmaceuticals Ltd. has announced the submission of a New Drug Application to the U.S. Food and Drug Administration (FDA) for TMC125 (etravirine), an investigational non- nucleoside reverse transcriptase inhibitor (NNRTI), being studied for use with other antiretroviral (ARV) agents as a treatment for people infected with HIV- 1.

19 Jul 2007

Progress in infectious disease surveillance but gaps remain

The key to control any pandemic is early identification and rapid response.

18 Jul 2007

Orchestra Therapeutics discontinues HIV vaccine program

Orchestra Therapeutics, Inc. has announced the discontinuation of its HIV Vaccine Development Program.

18 Jul 2007

HIV-infected children may require repeat measles vaccination

The researchers found that only half of the HIV-infected children who survived without antiretroviral therapy maintained protective antibody levels 27 months after receiving measles vaccine.

18 Jul 2007

Governments tackle interpersonal violence

Governments around the world are taking new and stronger measures to quell interpersonal violence and its life-long health consequences, a new WHO report shows.

18 Jul 2007

Starpharma announces VivaGel to be used as a condom coating

Starpharma Holdings Limited today announced that it has signed an agreement with a leading condom company in relation to the use of VivaGel as a condom coating.

17 Jul 2007

Insights into side effects of HIV protease inhibitors

UCLA scientists, along with collaborators from Purdue University, have demonstrated that HIV protease inhibitors, crucial drugs for HIV treatment block a cellular enzyme important for generating the structural scaffolding for the cell nucleus.

17 Jul 2007

Fast market penetration for Roche HIV viral load monitoring test

One-third of Roche Diagnostics' molecular customer base has already purchased or ordered the COBAS AmpliPrep /COBAS TaqMan HIV-1 assay, just eight weeks after the assay received approval from the Food & Drug Administration to go to market.

From Roche Sequencing and Life Science 17 Jul 2007

Latest in HIV/TB research

With HIV infection driving a deadly resurgence of tuberculosis (TB), a new publication provides up-to-date recommendations for clinicians facing the many challenges of treating patients with both of these two complex diseases.

17 Jul 2007

A challenge to the ancient origin of SIVagm based on African Green Monkey mitochondrial genomes

Monkey viruses related to HIV may have swept across Africa more recently than previously thought, according to new research from The University of Arizona in Tucson.

17 Jul 2007

Fewer teens getting pregnant and more using condoms

According to a new report by the Federal Interagency Forum on Child and Family Statistics, in 2005 the teenage birth rate in the U.S. reached an all time low and more high school students were using condoms.

16 Jul 2007

Trial examines diaphragm use in preventing HIV in women

A clinical trial involving 5,045 women in South Africa and Zimbabwe found no statistical difference in the rate of new HIV infections in the two study arms: those who received a diaphragm plus lubricant along with male condoms for their partners and those who only received male condoms.

13 Jul 2007

Clinical responses to antiretroviral drug therapy simulated for the first time

Treatment of HIV patients must balance the need to suppress viral replication against the harmful side effects and significant cost to the patient of antiretroviral therapy.

13 Jul 2007

Senate Health Committee votes to repeal written informed consent in HIV testing bill (AB 682), notes AHF

AIDS Healthcare Foundation (AHF), the US' largest provider of HIV/AIDS healthcare, prevention and education, and operator of the largest non-government HIV testing program in California which conducts more than 15,000 HIV tests annually, has lauded the California State Senate Health Committee for its vote in favor of Assembly Bill 682, California's Routine HIV Screening Bill, which will now move on to the Senate Appropriations Committee.

12 Jul 2007

Larger HIV prevention programs are cheaper

A UCSF-led team of researchers has found that larger HIV prevention programs in low and middle-income countries can increase efficiency and cause program unit costs to plummet. HIV prevention programs in Uganda, South Africa, Mexico, Russia and India were examined.

12 Jul 2007

Calypte announces India approval for HIV test

Calypte Biomedical Corporation has announced that it has received registration and marketing approval for its Aware HIV-1/2 OMT (oral fluid) rapid test in India from the Central Drugs Standard Control Organisation, commonly referred to as the Drug Control Authority of India ("DCAI").

12 Jul 2007

Vaginal health

Silence may impact women's health since few women or their doctors are comfortable talking about vaginal health openly.

11 Jul 2007

Potential role of milk thistle as an anticancer agent

Milk thistle extract, an herbal remedy since the times of the ancient Greeks and Romans, is today one of the most popular herbal supplements, with U.S. retail sales of nearly nine million dollars.

11 Jul 2007